Selected research
Industry Research
Monogenic Disease Testing Industry Research Report 2026
Market perspective
The global Monogenic Disease Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Monogenic Disease Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Monogenic Disease Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Monogenic Disease Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Monogenic Disease Testing include Celera Support Services, Abbott, ELITech Group, Auto Genomics, PerkinElmer and Bio-Rad Laboratories, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Monogenic Disease Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Monogenic Disease Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Monogenic Disease Testing Market by Company
Celera Support Services
Abbott
ELITech Group
Auto Genomics
PerkinElmer
Bio-Rad Laboratories
Monogenic Disease Testing Segment by Type
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive and Pre-Symptomatic Testing
Prenatal Testing
Monogenic Disease Testing Segment by Application
Hospitals
Clinics
Others
Monogenic Disease Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Monogenic Disease Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Monogenic Disease Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Monogenic Disease Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Monogenic Disease Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Carrier Testing
- Diagnostic Testing
- New-Born Screening
- Predictive and Pre-Symptomatic Testing
- Prenatal Testing
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Celera Support Services
- Abbott
- ELITech Group
- Auto Genomics
- PerkinElmer
- Bio-Rad Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Monogenic Disease Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Carrier Testing
- 2.2.3 Diagnostic Testing
- 2.2.4 New-Born Screening
- 2.2.5 Predictive and Pre-Symptomatic Testing
- 2.2.6 Prenatal Testing
- 2.3 Monogenic Disease Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Clinics
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Monogenic Disease Testing Breakdown Data by Type
- 3.1 Global Monogenic Disease Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Monogenic Disease Testing Forecasted Market Size by Type (2027-2032)
4 Monogenic Disease Testing Breakdown Data by Application
- 4.1 Global Monogenic Disease Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Monogenic Disease Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Monogenic Disease Testing Market Perspective (2021-2032)
- 5.2 Global Monogenic Disease Testing Growth Trends by Region
- 5.2.1 Global Monogenic Disease Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Monogenic Disease Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Monogenic Disease Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Monogenic Disease Testing Market Dynamics
- 5.3.1 Monogenic Disease Testing Industry Trends
- 5.3.2 Monogenic Disease Testing Market Drivers
- 5.3.3 Monogenic Disease Testing Market Challenges
- 5.3.4 Monogenic Disease Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Monogenic Disease Testing Players by Revenue
- 6.1.1 Global Top Monogenic Disease Testing Players by Revenue (2021-2026)
- 6.1.2 Global Monogenic Disease Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Monogenic Disease Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Monogenic Disease Testing Head Office and Area Served
- 6.4 Global Monogenic Disease Testing Players, Product Type & Application
- 6.5 Global Monogenic Disease Testing Manufacturers Established Date
- 6.6 Global Monogenic Disease Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Monogenic Disease Testing Market Size (2021-2032)
- 7.2 North America Monogenic Disease Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Monogenic Disease Testing Market Size by Country (2021-2026)
- 7.4 North America Monogenic Disease Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Monogenic Disease Testing Market Size (2021-2032)
- 8.2 Europe Monogenic Disease Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Monogenic Disease Testing Market Size by Country (2021-2026)
- 8.4 Europe Monogenic Disease Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Monogenic Disease Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Monogenic Disease Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Monogenic Disease Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Monogenic Disease Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Monogenic Disease Testing Market Size (2021-2032)
- 10.2 South America Monogenic Disease Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Monogenic Disease Testing Market Size by Country (2021-2026)
- 10.4 South America Monogenic Disease Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Monogenic Disease Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Monogenic Disease Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Monogenic Disease Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Monogenic Disease Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Celera Support Services
- 12.1.1 Celera Support Services Company Information
- 12.1.2 Celera Support Services Business Overview
- 12.1.3 Celera Support Services Revenue in Monogenic Disease Testing Business (2021-2026)
- 12.1.4 Celera Support Services Monogenic Disease Testing Product Portfolio
- 12.1.5 Celera Support Services Recent Developments
- 12.2 Abbott
- 12.2.1 Abbott Company Information
- 12.2.2 Abbott Business Overview
- 12.2.3 Abbott Revenue in Monogenic Disease Testing Business (2021-2026)
- 12.2.4 Abbott Monogenic Disease Testing Product Portfolio
- 12.2.5 Abbott Recent Developments
- 12.3 ELITech Group
- 12.3.1 ELITech Group Company Information
- 12.3.2 ELITech Group Business Overview
- 12.3.3 ELITech Group Revenue in Monogenic Disease Testing Business (2021-2026)
- 12.3.4 ELITech Group Monogenic Disease Testing Product Portfolio
- 12.3.5 ELITech Group Recent Developments
- 12.4 Auto Genomics
- 12.4.1 Auto Genomics Company Information
- 12.4.2 Auto Genomics Business Overview
- 12.4.3 Auto Genomics Revenue in Monogenic Disease Testing Business (2021-2026)
- 12.4.4 Auto Genomics Monogenic Disease Testing Product Portfolio
- 12.4.5 Auto Genomics Recent Developments
- 12.5 PerkinElmer
- 12.5.1 PerkinElmer Company Information
- 12.5.2 PerkinElmer Business Overview
- 12.5.3 PerkinElmer Revenue in Monogenic Disease Testing Business (2021-2026)
- 12.5.4 PerkinElmer Monogenic Disease Testing Product Portfolio
- 12.5.5 PerkinElmer Recent Developments
- 12.6 Bio-Rad Laboratories
- 12.6.1 Bio-Rad Laboratories Company Information
- 12.6.2 Bio-Rad Laboratories Business Overview
- 12.6.3 Bio-Rad Laboratories Revenue in Monogenic Disease Testing Business (2021-2026)
- 12.6.4 Bio-Rad Laboratories Monogenic Disease Testing Product Portfolio
- 12.6.5 Bio-Rad Laboratories Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst